Completed

Age: 1Month +
All Genders
ID00001503

Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols

Led by National Cancer Institute (NCI) · Updated on 2023-06-18

1031

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.

CONDITIONS

Official Title

Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease

Who Can Participate

Age: 1Month +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • ELIGIBILITY CRITERIA:

Patients of any age who were previously enrolled on a CCR protocol.

Not eligible for or unwilling to participate in an active NCI intramural primary research protocol.

CCR investigator decides it is in the best interests of the patient and the CC for the patient to be seen in follow-up visits at the NIH.

Patient or Legally Authorized Representative (LAR)/guardian is able to provide informed consent.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Total: 1 location

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892

Status Unknown

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Investigating Key Non-coding RNAs and Their Interaction with...

Breast Cancer

Actively Recruiting

1 location

Metabolic Tracing of Tumour and T Cells Using [U-13C]Glucose...

Ovarian Cancer

Actively Recruiting

1 location

Study of 177Lu-BetaBart, an Anti-B7-H3 Antibody, for Safety ...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here